Clinical Trials on Acne Papulopustulosa in Japan

Total 9 results

GlaxoSmithKline

Completed

Japanese Phase 1 Study of GSK2585823 (JPN P1)

Acne Vulgaris

Japan
GlaxoSmithKline

Completed

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

Acne Vulgaris

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

Acne Vulgaris

Japan
GlaxoSmithKline

Completed

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

Acne Vulgaris

Japan
GlaxoSmithKline

Completed

Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects

Acne Vulgaris

Japan
Galderma R&D

Completed

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
GlaxoSmithKline

Completed

DUAC® Early Onset Efficacy Study in Japanese Subjects

Acne Vulgaris

Japan
Galderma R&D

Completed

Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Galderma R&D

Completed

A Long Term Study of GK530G in Subjects With Acne Vulgaris

Acne Vulgaris

Japan

3

Subscribe